Curewize is a leader in the field of personalized medicine, diagnostics and predictive medicine with the goal of improving the survival rate and overall health outcome of cancer patients.
Curewize products are based on its proprietary platform technology for quantifying microRNA in patient biofluids, the master regulators of gene activity. Curewize lead product is ProALL a bone marrow lab test for deciding on Acute Lymphoblastic Leukemia (ALL) patients' treatment regimen. Results are available within 72 hours vs. 1 to 3 months of the gold standard lab test. Curewize pipeline includes a blood test, ProALL-BL, for long-term and frequent monitoring of ALL patients health, and a companion diagnostic lab test for deciding on the treatment of solid cancer patients.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 1 Hatzimicha St., Yokneam,<none> 2069207,israel
- Phone
- 97246230479
- Industry
- Biotechnology
- Website
- curewize.com
- HQ
- Yokneam, <None>
- Competitors
- Glycominds, LLC.
Curewize Health Ltd. Questions
Curewize Health Ltd.'s helpline number is 97246230479
Curewize Health Ltd.'s website is curewize.com
Curewize Health Ltd.'s LinkedIn profile is https://il.linkedin.com/company/curewize-health
Curewize Health Ltd. has
1 employees.
View email and phone details for 1
employees at Curewize Health Ltd..
Curewize Health Ltd.'s industry is
Biotechnology
Curewize Health Ltd.'s top competitors are
Glycominds, Llc.
Curewize Health Ltd.'s categories are Biotechnology
Curewize Health Ltd.'s founding year is 2013
